Pelvic Floor Electric Stimulator Market Size - By Product Type (Mobile, Fixed), By Application (Urinary Incontinence, Neurodegenerative Diseases, Sexual Dysfunction), By End-use– Global Forecast ,2023-2032

Pelvic Floor Electric Stimulator Market Size

Pelvic Floor Electric Stimulator Market size was valued at USD 221.3 million in 2022 and is estimated to account for USD 640 million by 2032. A pelvic floor electric stimulator is a medical device used to strengthen and rehabilitate the pelvic floor muscles.
 

The pelvic floor muscles support the bladder, uterus, and rectum, and weakening of these muscles can lead to issues such as urinary incontinence and pelvic organ prolapse. The stimulator delivers mild electrical impulses to the pelvic floor muscles through small electrodes, causing them to contract and relax rhythmically through the process of electrical muscle stimulation (EMS) or neuromuscular electrical stimulation (NMES).
 

Urinary incontinence is a widespread condition that affects millions of people, particularly women, worldwide. Several factors contribute to its prevalence, including pregnancy and childbirth, menopause, obesity, and certain medical conditions. As the population ages and the incidence of risk factors increases, the number of individuals experiencing urinary incontinence is on the rise. For instance, according to a report from the National Library of Medicine, which is part of the National Institutes of Health (NIH), approximately 423 million individuals aged 20 years and older worldwide experience some form of urinary incontinence. Additionally, healthcare organizations, patient advocacy groups, and government agencies have collaborated on awareness campaigns to destigmatize these conditions and encourage people to seek help.
 

COVID-19 Impact

During the COVID-19 pandemic, the pelvic floor electric stimulator market experienced a negative impact initially. Many non-urgent treatments for pelvic floor disorders were postponed or cancelled to prioritize COVID-19 patients and conserve healthcare resources. Additionally, consumer spending on non-essential products, including medical devices including pelvic floor electric stimulators, declined as people focused on essential goods and services amid uncertain economic conditions. Increased awareness about pelvic floor disorders and available treatments, along with the adoption of telehealth and remote monitoring.
 

Pelvic Floor Electric Stimulator Market Trends

 Aging is a major risk factor for pelvic floor disorders, as the muscles in the pelvic region weaken over time. For instance, according to the World Health Organization (WHO), the proportion of people aged 60 years or over is projected to increase significantly by 2030, with one in six individuals falling within this age group. Furthermore, between 2020 and 2050, the number of individuals aged 80 years or older is projected to triple, reaching a staggering 426 million.
 

Additionally, patients are increasingly seeking non-invasive or minimally invasive treatment options for various medical conditions. These devices offer a conservative and self-administered approach that allows patients to take control of their treatment at homecare settings.
 

Pelvic Floor Electric Stimulator Market Analysis

The pelvic floor electric stimulator market by product type is categorized into mobile and fixed. The mobile segment garnered USD 142.4 million revenue size in the year 2022. Mobile stimulators offer convenience and portability, enabling users to discreetly perform pelvic floor exercises anywhere they go. This smart home healthcare treatment option enhances accessibility, especially for individuals residing in remote areas. The presence of advanced features, such as smartphone connectivity and personalized tracking, engages users and motivates them to maintain consistent usage. Additionally, increasing penetration of smartphones and consumer preference for non-invasive solutions.
 

Based on application, the pelvic floor electric stimulator market is segmented into urinary incontinence, neurodegenerative diseases, and sexual dysfunction. The urinary incontinence segment garnered USD 176.3 million revenue size in the year 2022. The increasing prevalence of urinary incontinence, particularly among the aging population base, has driven the demand for effective and non-invasive treatment options. Patients' preference for conservative solutions, along with the endorsement of pelvic floor electric stimulators by healthcare professionals. As more individuals seek convenient and efficient ways to manage urinary incontinence and improve their quality of life, the demand for pelvic floor electric stimulators.
 

Based on end-use, the pelvic floor electric stimulator market is segmented into hospitals, clinics, home care settings, and others. The hospitals segment accounted for over 52.4% market share in the year 2022.
Hospitals play a crucial role as specialized treatment facilities, offering comprehensive pelvic floor health services, including pelvic floor electrical stimulation, administered by skilled healthcare professionals. Moreover, a vast patient pool, the availability of improved technology, and attractive government initiatives.
 

U.S. pelvic floor electric stimulator market accounted for USD 84.9 million revenue size in 2022 due to the increasing geriatric population base along with the rising incidence of chronic diseases. As per the World Health Organization (WHO) report urinary incontinence risk in older individuals is influenced by multiple chronic conditions such as Parkinson's disease, diabetes mellitus, dementia, prostatic cancer, stroke, chronic obstructive pulmonary disease (COPD), and arthritis. For instance, according to a U.S. Census Bureau report, the number of people aged 65 years and older is projected to reach around 78.0 million by the year 2035. Additionally, the Parkinson's Foundation reports that approximately 60,000 individuals receive a Parkinson's disease diagnosis annually in the U.S.
 

Pelvic Floor Electric Stimulator Market Share

Some of the eminent market participants operating in the pelvic floor electric stimulator market include:

• Zynex Inc
• TensCare Ltd
• Verity Medical Ltd
• InControl Medical
• The Prometheus Group
• Laborie, Inc
• Athena Feminine Technologies
• Renovia Inc
• Nidd Valley Medical Ltd
•  Everyway Medical Instruments Co., Ltd
   

Pelvic Floor Electric Stimulator Industry News:

• In June 2021, Laborie Medical Technologies and Urotronic Inc. announced the successful completion of the first Optilume procedures in the United Kingdom's National Health Service (NHS). Such initiatives enable industry expansion.
   
• In March 2019, InControl Medical obtained FDA approval for the first over the counter at-home pelvic floor electrical stimulation devices to treat urinary incontinence among women in the U.S. This has helped company to strengthen its product offerings.
   

Pelvic floor electric stimulator market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032 for the following segments:

Click here to Buy Section of this Report

By Product Type (USD Million & Units)

• Mobile
• Fixed

By Application (USD Million)

• Urinary incontinence
• Neurodegenerative diseases
• Sexual dysfunction

By End-use (USD Million)

• Hospitals
• Clinics
• Home care settings
• Others

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Switzerland
  • The Netherlands
  • Denmark
  • Poland
  • Sweden
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • New Zealand
  • Thailand
  • Vietnam
  • Indonesia
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Chile
• Middle East & Africa
  • Saudi Arabia
  • South Africa
  • UAE
  • Turkey